CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (319,819)	$ 94,976
Adjustments to reconcile net income (loss) to net cash used in operating activities
Gain on disposal of subsidiary	0	(340,743)
Non-controlling interest	0	(31,375)
Depreciation	7,582	4,607
Allowance for bad debt	0	12,700
Beneficial conversion feature expense	0	9,439
Amortization of debt issuance cost	0	1,888
Share based compensation	750	0
(Increase) decrease in current assets:
Accounts receivable	(45,661)	138,223
Advance to supplier	0	(4,900)
Inventory	(283,753)	(152,839)
Other current assets	2,615	0
Increase (decrease) in current liabilities:
Accounts payable & accrued expenses	430,805	165,974
Accounts payable - related parties	0	(1,612)
Advances from customers	6,551	(9,048)
Net cash used in operating activities - continuing operations	(200,931)	(112,710)
Net cash used in operating activities	(200,931)	(112,710)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(5,060)	(12,786)
Due from related party	(1,000)	(1,000)
Net cash used in investing activities - continuing operations	(6,060)	(13,786)
Net cash used in investing activities	(6,060)	(13,786)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from related party notes payable	20,000	0
Proceeds from notes payable & debentures	168,000	0
Net cash provided by financing activities - continuing operations	188,000	0
Net cash provided by financing activities - discontinued operations	0	63,918
Net cash provided by financing activities	188,000	63,918
NET DECREASE IN CASH & CASH EQUIVALENTS	(18,990)	(62,579)
CASH & CASH EQUIVALENTS, BEGINNING BALANCE	39,444	102,022
CASH & CASH EQUIVALENTS, ENDING BALANCE	20,454	39,444
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	4,301	0
Income taxes paid	6,800	0
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Series B preferred shares issued for debt and accrued interest	750
Convertible debenture converted from notes payable and accrued interest	0	204,700
Forgiveness of accounts payable-related parties	0	75,450
Common Stock issued as loan fee	750	0
Series B preferred shares issued to acquire non-controlling interest in subsidiary	0	2,400,000
Series B preferred shares cancelled in lieu of sale of subsidiary	$ 0	$ 264,382